ATS Medical has gained FDA approval and market release of the ATS Simulus annuloplasty product line, expanding the company's portfolio to include the repair segment of the heart valve therapy market.
ATS Simulus annuloplasty products are available either in a flexible ring, the ATS Simulus FLX-O Ring (or a flexible band) or the ATS Simulus FLX-C Band to accommodate various approaches to valve repair. They can be used in both the mitral and tricuspid position. Annuloplasty rings and bands are used in those cases where repair of patient's heart valve is preferable to the complete replacement of the valve. It has been well documented that the shape of heart valves change during the cardiac cycle. The ATS Simulus annuloplasty products are designed to maintain the normal physiologic function of the heart valve. They have been designed with the input of cardiac surgeons with a focus on the ease of implantation.
Genesee BioMedical, a Denver-based innovator of cardiac surgery instruments and devices recognized for its high standards of quality, is the exclusive partner of ATS Medical for the development and manufacture of a full line of annuloplasty products.
"The ATS Simulus annuloplasty product line is yet another vital step in our mission to establish ATS Medical as a leader in cardiac surgery," said ATS Medical Chairman, President and CEO Michael D Dale.
|
